INDV Indivior Pharmaceuticals, Inc. - Common Stock
$37,88
Fiyat · May 20, 2026
Temel veriler itibarıyla Nis 30, 2026
52 Haftlık Aralık
$11–$41
90% of range
Analist Derecelendirmesi
BUY
12 analysts
Fiyat Hedefi
$52
+36% upside
P/E (TTM)
21.9
ROE
-118.3%
Net Kâr Marjı
17.0%
INDV Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$37.88
Piyasa Değeri
—
P/E (TTM)
21.9
EPS (TTM)
$1.64
Gelir (TTM)
$1.24B
Temettü Verimi
—
ROE
-118.3%
D/E Borç/Özsermaye
-3.3
52 Haftlık Aralık
$11 – $41
INDV Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$1.24B
2022-12-31
→
2025-12-31
Hisse Başına Kâr
$1.64
2022-12-31
→
2025-12-31
Serbest Nakit Akışı
$-93M
2024-12-31
→
2025-12-31
Marjlar
17.0%
2024-12-31
→
2025-12-31
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
INDV
Akran Ortalaması
P/E (TTM)
21.9
34.5
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
INDV
Akran Ortalaması
Gross Margin (Brüt Kar Marjı)
80.2%
88.6%
Operating Margin (Faaliyet Kâr Marjı)
21.1%
—
Net Profit Margin (Net Kâr Marjı)
17.0%
10.6%
ROA
16.7%
1.2%
ROE
-118.3%
4.0%
ROIC
104.2%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
INDV
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
-3.3
139.5
Current Ratio (Cari Oran)
0.7
2.1
Quick Ratio (Cari Oran)
0.5
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
INDV
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
4.3%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
11.2%
—
EPS YoY (EPS YB)
3180.0%
—
Net Income YoY (Net Gelir Yıllık Bazda)
2900.0%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
INDV
Akran Ortalaması
INDV Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
12 analist
- Güçlü Al 4 33,3%
- Al 7 58,3%
- Tut 1 8,3%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
6 analist · 2026-05-15
Medyan
$50.00
Ortalama
$51.50
← Tüm hedeflerin altında
$37.88
Düşük
$48.00
Yüksek
$59.00
Medyan hedef
$50.00
+32,0%
Ortalama hedef
$51.50
+36,0%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.23%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $0.96 | $0.67 | 0.29% |
| 31 Aralık 2025 | $0.82 | $0.69 | 0.13% |
| 30 Eylül 2025 | $0.72 | $0.42 | 0.30% |
| 30 Haziran 2025 | $0.51 | $0.27 | 0.24% |
| 31 Mart 2025 | $0.41 | $0.24 | 0.17% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| INDV | — | 21.9 | 4.3% | 17.0% | -118.3% | 80.2% |
| ELAN | $11.25B | -48.1 | 6.2% | -4.9% | -3.5% | 55.0% |
| CORT | $3.69B | 42.4 | 12.8% | 13.1% | 15.5% | — |
| BLTE | — | — | — | — | — | — |
| LQDA | $3.01B | -43.1 | 1031.2% | -43.5% | -230.0% | — |
| LGND | $3.74B | 30.8 | 60.4% | 46.4% | 13.5% | — |
| MANE | — | — | — | — | 82.6% | — |
| AMRX | — | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| CRNX | $4.45B | -9.4 | 640.7% | -6046.2% | -43.0% | — |
| OGN | $1.87B | 10.0 | -2.9% | 3.0% | 25.2% | 53.3% |
| EWTX | $2.64B | -15.2 | — | — | -30.2% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 15
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $1.24B | $1.19B | $1.09B | $901M | |
| Cost of Revenue | $246M | $231M | $174M | $151M | |
| Gross Profit | $994M | $957M | $919M | $749M | |
| SG&A Expense | $634M | $612M | $565M | $466M | |
| Operating Expenses | · | $919M | $1.07B | $827M | |
| Operating Income | $262M | $38M | $-152M | $-77M | |
| Interest Income | $22M | $23M | $43M | $19M | |
| Pretax Income | $239M | $20M | $-145M | $-86M | |
| Income Tax | $29M | $13M | $-19M | $-43M | |
| Net Income | $210M | $7M | $-126M | $-42M | |
| EPS (Basic) | $1.68 | $0.05 | $-0.92 | $-0.30 | |
| EPS (Diluted) | $1.64 | $0.05 | $-0.92 | $-0.30 | |
| Shares (Basic) | 125,000,000 | 132,000,000 | 137,000,000 | 139,000,000 | |
| Shares (Diluted) | 128,000,000 | 133,000,000 | 137,000,000 | 139,000,000 | |
| EBITDA | $272M | $61M | · | · |
Bilanço 26
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $195M | $319M | $316M | · | |
| Short-term Investments | $0 | $1M | $94M | · | |
| Receivables | $253M | $254M | $254M | · | |
| Inventory | $153M | $167M | $126M | · | |
| Prepaid Expense | $34M | $31M | $52M | · | |
| Other Current Assets | $16M | $21M | · | · | |
| Current Assets | $652M | $827M | $1.26B | · | |
| PP&E (Net) | $144M | $100M | $84M | · | |
| PP&E (Gross) | $251M | $190M | $165M | · | |
| Accum. Depreciation | $107M | $90M | $81M | · | |
| Goodwill | $2M | $2M | $5M | · | |
| Other Non-current Assets | $27M | $39M | $36M | · | |
| Total Assets | $1.20B | $1.32B | $1.76B | · | |
| Accounts Payable | $48M | $63M | $39M | · | |
| Current Liabilities | $914M | $924M | $1.28B | · | |
| Capital Leases | $22M | $32M | $34M | · | |
| Other Non-current Liabilities | $21M | $18M | $31M | · | |
| Total Liabilities | $1.30B | $1.65B | $1.94B | · | |
| Long-term Debt | $319M | $333M | $240M | · | |
| Total Debt | $319M | $333M | · | · | |
| Common Stock | $62M | $62M | $68M | · | |
| Paid-in Capital | $112M | $90M | $88M | · | |
| Retained Earnings | $-243M | $-443M | $-288M | · | |
| AOCI | $-30M | $-36M | $-30M | · | |
| Stockholders' Equity | $-98M | $-337M | $-184M | $-15M | |
| Liabilities + Equity | $1.20B | $1.32B | $1.76B | · |
Nakit Akışı 15
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $10M | $16M | $15M | $16M | |
| Stock-based Comp | $26M | $24M | $21M | $16M | |
| Deferred Tax | $-46M | $7M | $-64M | $-104M | |
| Other Non-cash | $-227M | $-25M | · | · | |
| Operating Cash Flow | $-27M | $36M | $-300M | $-4M | |
| CapEx | $66M | $29M | $8M | $5M | |
| Investing Cash Flow | $-66M | $69M | $-95M | $-222M | |
| Debt Issued | $0 | $332M | $0 | $0 | |
| Net Debt Issued | $-17M | $92M | · | · | |
| Stock Issued | $2M | $3M | $3M | $2M | |
| Stock Repurchased | $11M | $173M | $33M | $90M | |
| Net Stock Activity | $-9M | $-170M | · | · | |
| Financing Cash Flow | $-30M | $-102M | $-64M | $-101M | |
| Taxes Paid | $38M | $46M | $32M | $57M | |
| Free Cash Flow | $-93M | $7M | · | · |
Kârlılık 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Gross Margin | 80.2% | 80.6% | · | · | |
| Operating Margin | 21.1% | 2.7% | · | · | |
| Net Margin | 17.0% | 0.17% | · | · | |
| Pretax Margin | 19.3% | 1.2% | · | · | |
| EBITDA Margin | 21.9% | 5.1% | · | · | |
| ROA | 16.7% | 0.13% | · | · | |
| ROE | -118.3% | -0.61% | · | · | |
| ROIC | 104.2% | -45.7% | · | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 0.7 | 0.9 | · | · | |
| Quick Ratio | 0.5 | 0.6 | · | · | |
| Debt / Equity | -3.3 | -1.0 | · | · | |
| LT Debt / Equity | -3.0 | -0.9 | · | · |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.8 | · | · | |
| Inventory Turnover | 1.5 | 1.5 | · | · | |
| Receivables Turnover | 4.9 | 4.7 | · | · |
Büyüme Oranları 4
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 4.3% | 8.7% | 21.3% | · | |
| Revenue CAGR 3Y | 11.2% | · | · | · | |
| EPS YoY | 3180.0% | · | · | · | |
| Net Income YoY | 2900.0% | · | · | · |
Değerleme (TTM) 4
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $1.24B | $1.19B | · | · | |
| Net Income TTM | $210M | $7M | · | · | |
| P/E | 21.9 | 248.6 | · | · | |
| Earnings Yield | 4.6% | 0.40% | · | · |
Gelir Tablosu 15
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $317M | $357M | $314M | $302M | $266M | $298M | $307M | $299M | $284M | |
| Cost of Revenue | $40M | $67M | $83M | $52M | $44M | $48M | $66M | $79M | $38M | |
| Gross Profit | $277M | $293M | $230M | $250M | $221M | $250M | $241M | $220M | $246M | |
| SG&A Expense | $124M | $189M | $155M | $158M | $133M | $175M | $142M | $152M | $143M | |
| Operating Expenses | $139M | · | $187M | · | $156M | $205M | $206M | $338M | $171M | |
| Operating Income | $137M | $81M | $43M | $72M | $66M | $46M | $35M | $-118M | $75M | |
| Interest Income | $3M | $6M | $6M | $6M | $4M | $5M | $5M | $6M | $7M | |
| Pretax Income | $115M | $81M | $37M | $62M | $59M | $38M | $30M | $-121M | $73M | |
| Income Tax | $26M | $-21M | $-5M | $44M | $11M | $17M | $8M | $-23M | $11M | |
| Net Income | $89M | $103M | $42M | $18M | $47M | $21M | $22M | $-97M | $61M | |
| EPS (Basic) | $0.71 | $0.81 | $0.34 | $0.15 | $0.38 | $0.16 | $0.16 | $-0.72 | $0.45 | |
| EPS (Diluted) | $0.69 | $0.79 | $0.33 | $0.14 | $0.38 | $0.16 | $0.16 | $-0.72 | $0.45 | |
| Shares (Basic) | 124,000,000 | -249,000,000 | 125,000,000 | 125,000,000 | 124,000,000 | -271,000,000 | 132,000,000 | 135,000,000 | 136,000,000 | |
| Shares (Diluted) | 129,000,000 | -252,000,000 | 129,000,000 | 126,000,000 | 125,000,000 | -272,000,000 | 133,000,000 | 135,000,000 | 137,000,000 | |
| EBITDA | $139M | · | $43M | $72M | $71M | · | · | · | · |
Bilanço 26
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $175M | $195M | $445M | $510M | $372M | $319M | · | · | · | |
| Short-term Investments | · | $0 | $0 | $0 | $1M | $1M | · | · | · | |
| Receivables | $273M | $253M | $259M | $240M | $243M | $254M | · | · | · | |
| Inventory | $152M | $153M | $155M | $149M | $163M | $167M | · | · | · | |
| Prepaid Expense | $15M | $34M | $30M | $28M | $56M | $31M | · | · | · | |
| Other Current Assets | $40M | $16M | $19M | $20M | $20M | $21M | · | · | · | |
| Current Assets | $667M | $652M | $922M | $951M | $883M | $827M | · | · | · | |
| PP&E (Net) | $157M | $144M | $124M | $117M | $104M | $100M | · | · | · | |
| PP&E (Gross) | $268M | $251M | $230M | $210M | $197M | $190M | · | · | · | |
| Accum. Depreciation | $111M | $107M | $106M | $93M | $92M | $90M | · | · | · | |
| Goodwill | · | $2M | · | · | · | $2M | · | · | · | |
| Other Non-current Assets | $26M | $27M | $27M | $44M | $39M | $39M | · | · | · | |
| Total Assets | $1.20B | $1.20B | $1.42B | $1.45B | $1.38B | $1.32B | · | · | · | |
| Accounts Payable | $35M | $48M | $41M | $50M | $46M | $63M | · | · | · | |
| Current Liabilities | $779M | $914M | $965M | $1.06B | $1.00B | $924M | · | · | · | |
| Capital Leases | $14M | $22M | $24M | $29M | $30M | $32M | · | · | · | |
| Other Non-current Liabilities | $21M | $21M | $30M | $18M | $17M | $18M | · | · | · | |
| Total Liabilities | $1.34B | $1.30B | $1.62B | $1.71B | $1.66B | $1.65B | · | · | · | |
| Long-term Debt | $486M | $319M | $322M | $326M | $329M | $333M | · | · | · | |
| Total Debt | $486M | · | $322M | $326M | $329M | · | · | · | · | |
| Common Stock | $0 | $62M | $62M | $62M | $62M | $62M | · | · | · | |
| Paid-in Capital | $165M | $112M | $109M | $101M | $93M | $90M | · | · | · | |
| Retained Earnings | $-280M | $-243M | $-346M | $-388M | $-406M | $-443M | · | · | · | |
| AOCI | $-29M | $-30M | $-32M | $-33M | $-35M | $-36M | · | · | · | |
| Stockholders' Equity | $-144M | $-98M | $-207M | $-257M | $-285M | $-337M | · | · | · | |
| Liabilities + Equity | $1.20B | $1.20B | $1.42B | $1.45B | $1.38B | $1.32B | · | · | · |
Nakit Akışı 15
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $3M | $0 | $3M | $5M | $4M | $2M | $5M | |
| Stock-based Comp | $9M | $5M | $7M | $8M | $6M | $6M | $6M | $6M | $6M | |
| Deferred Tax | $27M | $-38M | $-15M | $9M | $-2M | $37M | $-6M | $-27M | $3M | |
| Other Non-cash | $-136M | · | · | · | $19M | · | · | · | · | |
| Operating Cash Flow | $-9M | $-221M | $-39M | $158M | $75M | $-17M | $2M | $88M | $-37M | |
| CapEx | $20M | $24M | $20M | $17M | $5M | $16M | $7M | $4M | $2M | |
| Investing Cash Flow | $-19M | $-24M | $-20M | $-17M | $-5M | $8M | $35M | $1M | $25M | |
| Debt Issued | $489M | · | · | · | $0 | · | · | · | · | |
| Net Debt Issued | $156M | · | · | · | $-4M | · | · | · | · | |
| Stock Issued | $0 | $0 | $1M | $0 | $1M | $0 | $1M | $0 | $2M | |
| Stock Repurchased | $126M | $0 | $0 | $0 | $11M | $50M | $52M | $35M | $36M | |
| Net Stock Activity | $-126M | · | · | · | $-10M | · | · | · | · | |
| Financing Cash Flow | $7M | $-5M | $-3M | $-5M | $-17M | $40M | $-51M | $-35M | $-56M | |
| Net Change in Cash | · | · | · | · | $53M | · | · | · | $-68M | |
| Free Cash Flow | $-29M | · | · | · | $70M | · | · | · | · |
Kârlılık 8
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 87.4% | · | 73.2% | 82.8% | 83.1% | · | · | · | · | |
| Operating Margin | 43.2% | · | 13.7% | 23.8% | 24.8% | · | · | · | · | |
| Net Margin | 28.1% | · | 13.4% | 6.0% | 17.7% | · | · | · | · | |
| Pretax Margin | 36.3% | · | 11.8% | 20.5% | 22.2% | · | · | · | · | |
| EBITDA Margin | 43.9% | · | 13.7% | 23.8% | 26.7% | · | · | · | · | |
| ROA | 6.9% | · | 5.9% | 2.5% | 6.8% | · | · | · | · | |
| ROE | -41.5% | · | -40.6% | -14.0% | -33.0% | · | · | · | · | |
| ROIC | 31.0% | · | 42.4% | 30.3% | 122.0% | · | · | · | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | · | 1.0 | 0.9 | 0.9 | · | · | · | · | |
| Quick Ratio | 0.6 | · | 0.7 | 0.7 | 0.6 | · | · | · | · | |
| Debt / Equity | -3.4 | · | -1.6 | -1.3 | -1.2 | · | · | · | · | |
| LT Debt / Equity | -3.4 | · | -1.5 | -1.2 | -1.1 | · | · | · | · |
Verimlilik 3
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | · | 0.4 | 0.4 | 0.4 | · | · | · | · | |
| Inventory Turnover | 0.3 | · | 1.1 | 0.7 | 0.5 | · | · | · | · | |
| Receivables Turnover | 1.2 | · | 2.4 | 2.5 | 2.2 | · | · | · | · |
Değerleme (TTM) 4
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.20B | · | $1.19B | $1.17B | $1.16B | · | · | · | · | |
| Net Income TTM | $196M | · | $128M | $108M | $-7M | · | · | · | · | |
| P/E | 19.8 | · | 23.9 | -368.5 | 35.3 | · | · | · | · | |
| Earnings Yield | 5.1% | · | 4.2% | -0.27% | 2.8% | · | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Gelir | $1.24B | $1.19B | $1.09B | $901M |
| Brüt Kâr Marjı % | 80.2% | 80.6% | — | — |
| Faaliyet Kâr Marjı % | 21.1% | 2.7% | — | — |
| Net Gelir | $210M | $7M | $-126M | $-42M |
| Seyreltilmiş Hisse Başı Kâr | $1.64 | $0.05 | $-0.92 | $-0.30 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Borç / Öz Sermaye | -3.3 | -1.0 | — | — |
| Cari Oran | 0.7 | 0.9 | — | — |
| Cari Oran | 0.5 | 0.6 | — | — |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Serbest Nakit Akışı | $-93M | $7M | — | — |
Son Haberler Bu şirketten bahseden son manşetler
İşlem Sinyalleri Giriş fiyatı ve risk/ödül oranı ile son alım/satım sinyalleri
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.